Tiny study checks if two drugs clash in the body
NCT ID NCT07457203
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study will test how buagafuran capsules and voriconazole tablets affect each other in 18 healthy Chinese adults over 7 days. Researchers will measure drug levels in the blood and watch for side effects. The goal is simply to gather safety and interaction data, not to treat any disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- buagafuran and voriconazole
- What this could lead to
- If successful, this study could help doctors understand how to safely combine buagafuran with voriconazole in future treatments.
- What could go wrong
- This is a very early, small study in healthy people, not patients. It only looks at drug levels and safety, not whether the combination works for any disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRUG-DRUG INTERACTION (DDI) are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing Union Pharmaceutical Factory Ltd
Beijing, Beijing Municipality, 102600, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new drug alter the fate of common medications?
- New drug combo aims to shrink hard-to-treat tumors
- New drug safety check: how does JP-1366 mix with heart meds?
- New drug interaction study completed in 12 healthy volunteers
- Methotrexate drug interaction study aims to boost safety
- New antibiotic combo tested in healthy volunteers – no cure yet